Current Report Filing (8-k)
October 11 2022 - 08:31AM
Edgar (US Regulatory)
false 0001460329 0001460329 2022-10-11
2022-10-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 11,
2022
FLUENT, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
001-37893
|
77-0688094
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
300 Vesey Street, 9th Floor
New York, New York
|
10282
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(646) 669-7272
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4 (c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock,
$0.0005 par value per share |
|
FLNT |
|
The NASDAQ Stock
Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17
CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
(d) Election of Directors
On October 6, 2022, the Board of Directors (the "Board") of Fluent,
Inc. (the "Company") appointed David A. Graff and Richard C.
Pfenniger, Jr. as directors of the Company. Neither Mr. Graff
nor Mr. Pfenniger have been assigned to a Board committee at the
time of this filing.
Mr. Graff is currently Google’s Vice-President, Global Policy and
Standards, responsible for implementing content and behavioral
policy across all Google products. Prior to Google, Mr. Graff
served as the CEO of Online Intelligence, a technology start-up.
Previously, Mr. Graff was Chief Legal Officer for private equity
backed Edison Schools, Inc. where he managed the company’s IPO and
served as corporate secretary and securities compliance officer.
Mr. Graff serves on the board of advisors to CapitalG, Google’s
independent growth fund, consulting on investments and issues
related to digital fraud and abuse. In addition, he currently sits
on the Board of Visitors for The Georgetown University Law
Center.
Mr. Pfenniger is a private investor with significant executive and
operating experience in life science, healthcare and education
fields. Mr. Pfenniger served as the Chairman of the Board of
Directors and President and Chief Executive Officer of Continucare
Corporation, a provider of primary care physician services, from
2003 until the company was acquired in 2011. During his tenure as
CEO, Continucare’s share price increased approximately tenfold.
Prior to Continucare, Mr. Pfenniger served as Chief Executive
Officer and Vice Chairman of Whitman Education Group, Inc., as well
as an executive officer of IVAX Corporation, serving as its Chief
Operating Officer and its Senior Vice President – Legal Affairs and
General Counsel. Mr. Pfenniger currently serves as a director on
several health, pharmaceutical and medical company boards,
including: OPKO Health, Inc., Asensus Surgical, Inc., Cocrystal
Pharma, Inc., and Sema4 Holdings, Inc. He also serves as the Vice
Chairman of the Board of Trustees of the Phillip and Patricia Frost
Museum of Science in Miami, Florida and is a member of its
Executive Committee.
Neither Mr. Graff nor Mr. Pfenniger is a party to any related party
transaction reportable under Item 404(a) of Regulation S-K. Mr.
Graff and Mr. Pfenniger will participate in the Company’s
non-employee director compensation program, which is described in
the Company’s Definitive Proxy Statement filed with the U.S.
Securities and Exchange Commission on May 2, 2022.
Item 7.01 Regulation FD Disclosure
A copy of the press release announcing the events described in
Item 5.02(d) above is attached hereto as Exhibit 99.1 and is
incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
|
|
Description
|
|
|
|
|
|
Press Release, issued October 11, 2022
|
104 |
|
Cover Page Interactive
Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
Fluent, Inc.
|
|
|
|
|
|
October 11, 2022
|
By:
|
/s/ Donald Patrick
|
|
|
Name:
|
Donald Patrick
|
|
|
Title:
|
Chief Executive Officer
|
|
Fluent (NASDAQ:FLNT)
Historical Stock Chart
From May 2023 to Jun 2023
Fluent (NASDAQ:FLNT)
Historical Stock Chart
From Jun 2022 to Jun 2023